Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 76 results.
User Information
Export Records
  1. 1.   Prior SARS-Cov-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster
  2. Wachter, Brianna T; Xu, Qin; Shi, Lihong; Burbelo, Peter D; Myint-Hpu, Kathy; Schwartzberg, Pamela L; Rehman,Tauseef; Dewar,Robin; Boswell, Kristin L; Koup, Richard A; Oguz, Cihan; Imberti, Luisa; Bellusci, Lorenza; Pourhashemi, Sara; Khurana, Surender; Manthiram, Kalpana; Notarangelo, Luigi D; Delmonte, Ottavia M
  3. The journal of Allergy and Clinical Immunology. . 2025, Mar 03;
  1. 2.   Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions
  2. Crawford, James M; Penberthy, Lynne; Pinto,Ligia; Althoff, Keri N; Assimon, Magdalene M; Cohen, Oren; Gillim, Laura; Hammonds, Tracy L; Kapur, Shilpa; Kaufman, Harvey W; Kwasny, David; Liew, Jean W; Meyer, William A; Reynolds, Shannon L; Schleicher, Cheryl B; Subbiah, Suki; Theruviparampil, Catherine; Wallace, Zachary S; Warner, Jeremy L; Yoon, Suhyeon; Ziemba, Yonah C
  3. Open Forum Infectious Diseases. 2025, Jan; 12(1): ofaf021.
  1. 3.   Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination
  2. Bullock,Jimmie; Hickey,Thomas; Kemp,Troy; Metz,Jordan; Loftus,Sarah; Haynesworth,Katrina; Castro, Nicholas; Luke,Brian; Lowy, Douglas R; Pinto,Ligia
  3. Vaccines. 2024, May 09; 12(5):
  1. 4.   Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1
  2. Xu, Jianliang; Zhou, Tongqing; McKee, Krisha; Zhang, Baoshan; Liu, Cuiping; Nazzari, Alexandra F; Pegu, Amarendra; Shen, Chen-Hsiang; Becker, Jordan E; Bender, Michael F; Chan, Payton; Changela, Anita; Chaudhary, Ridhi; Chen, Xuejun; Einav, Tal; Kwon, Young Do; Lin, Bob C; Louder, Mark K; Merriam, Jonah S; Morano, Nicholas C; O'Dell, Sijy; Olia, Adam S; Rawi, Reda; Roark, Ryan S; Stephens,Tyler; Teng, I-Ting; Tourtellott-Fogt, Emily; Wang, Shuishu; Yang, Eun Sung; Shapiro, Lawrence; Tsybovsky,Yaroslav; Doria-Rose, Nicole A; Casellas, Rafael; Kwong, Peter D
  3. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2024, May 05; e2309268.
  1. 5.   Reactive Oxygen Species-Sensitive Biodegradable Mesoporous Silica Nanoparticles Harboring TheraVac Elicit Tumor-Specific Immunity for Colon Tumor Treatment
  2. Huang,Yue; Nahar, Saifun; Alam, Md Masud; Hu, Shuo; McVicar,Dan; Yang,De
  3. ACS Nano. 2023, Oct 13;
  1. 6.   Analysis of cervical HPV infections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine Trial
  2. Sierra, Mónica S; Tsang, Sabrina H; Porras, Carolina; Herrero, Rolando; Sampson, Joshua N; Cortes, Bernal; Schussler, John; Wagner,Sarah; Carvajal, Loretto; Quint, Wim; Kreimer, Aimée R; Hu, Shangying; Rodriguez, Ana Cecilia; Romero, Byron; Hildesheim, Allan
  3. Sexually Transmitted Infections. 2022, Jul 16;
  1. 7.   T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
  2. Naranbhai, Vivek; Nathan, Anusha; Kaseke, Clarety; Berrios, Cristhian; Khatri, Ashok; Choi, Shawn; Getz, Matthew A; Tano-Menka, Rhoda; Ofoman, Onosereme; Gayton, Alton; Senjobe, Fernando; Zhao, Zezhou; St Denis, Kerri J; Lam, Evan C; Carrington,Mary; Garcia-Beltran, Wilfredo F; Balazs, Alejandro B; Walker, Bruce D; Iafrate, A John; Gaiha, Gaurav D
  3. Cell. 2022, Feb 03; 185
  1. 8.   Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines
  2. Tuli, Hardeep Singh; Sak, Katrin; Aggarwal,Poonam; Iqubal, Ashif; Upadhaya, Sushil K.; Kaur, Jagjit; Kaur, Ginpreet; Aggarwal, Diwakar
  3. Frontiers in Cellular and Infection Microbiology. 2021, Dec 14; 11
  1. 9.   Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy
  2. Llopiz, Diana; Ruiz, Marta; Silva, Leyre; Reparaz, David; Aparicio, Belén; Egea, Josune; Lasarte, Juan J; Redin, Esther; Calvo, Alfonso; Angel,Matthew; Berzofsky, Jay A; Stroncek, David; Sarobe, Pablo
  3. Cancer Letters. 2021, Feb 28; 499: 279-289.
  1. 10.   Identification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent Elicitation
  2. Cheung, Crystal Sao-Fong; Fruehwirth, Alexander; Paparoditis, Philipp Carl Georg; Shen, Chen-Hsiang; Foglierini, Mathilde; Joyce, M Gordon; Leung, Kwanyee; Piccoli, Luca; Rawi, Reda; Silacci-Fregni, Chiara; Tsybovsky,Yaroslav; Verardi, Raffaello; Wang, Lingshu; Wang, Shuishu; Yang, Eun Sung; Zhang, Baoshan; Zhang, Yi; Chuang, Gwo-Yu; Corti, Davide; Mascola, John R; Shapiro, Lawrence; Kwong, Peter D; Lanzavecchia, Antonio; Zhou, Tongqing
  3. Cell reports. 2020, Sep 01; 32(9): 108088.
  1. 11.   Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer
  2. Abdul Sater, Houssein; Marté, Jennifer L; Donahue, Renee N; Walter-Rodriguez, Beatriz; Heery, Christopher R; Steinberg, Seth M; Cordes, Lisa M; Chun, Guinevere; Karzai, Fatima; Bilusic, Marijo; Harmon,Stephanie; Turkbey, Ismail Baris; Choyke, Peter L; Schlom, Jeffrey; Dahut, William L; Madan, Ravi A; Pinto, Peter A; Gulley, James L
  3. Journal for immunotherapy of cancer. 2020, Mar; 8(1): pii : jitc-2020-000655.
  1. 12.   PREVAIL I Cluster Vaccination Study With rVSV Delta G-ZEBOV-GP as Part of a Public Health Response in Liberia
  2. Bolay, Fatorma K.; Grandits, Greg; Lane, H. Clifford; Kennedy, Stephen B.; Johnson, Melvin P.; Fallah, Mosoka P.; Wilson, Barthalomew; Njoh,Wissedi; McNay, Laura A.; Hensley, Lisa E.; Higgs, Elizabeth S.
  3. JOURNAL OF INFECTIOUS DISEASES. 2019, May 15; 219(10): 1634-1641.
  1. 13.   Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies
  2. Duan, Hongying; Chen, Xuejun; Boyington, Jeffrey C; Cheng, Cheng; Zhang, Yi; Jafari, Alexander J; Stephens, Tyler; Tsybovsky, Yaroslav; Kalyuzhniy, Oleksandr; Zhao, Peng; Menis, Sergey; Nason, Martha C; Normandin, Erica; Mukhamedova, Maryam; DeKosky, Brandon J; Wells, Lance; Schief, William R; Tian, Ming; Alt, Frederick W; Kwong, Peter D; Mascola, John R
  3. Immunity. 2018, Aug 21; 49(2): 301-311.e5.
  1. 14.   Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection
  2. Munson, Paul; Liu, Yi; Bratt, Debra; Fuller, James T; Hu, Xintao; Pavlakis, George; Felber, Barbara; Mullins, James I; Fuller, Deborah Heydenburg
  3. Human vaccines & immunotherapeutics. 2018, Apr 12; 14(7): 1820-1831.
  1. 15.   DNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid beta-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's disease
  2. Olkhanud, P. B.; Mughal, M.; Ayukawa, K.; Malchinkhuu, E.; Bodogai, M.; Feldman, N.; Rothman, S.; Lee, J. H.; Chigurupati, S.; Okun, E.; Nagashima, K.; Mattson, M. P.; Biragyn, A.
  3. Vaccine. 2012, Feb; 30(9): 1650-1658.
  1. 16.   SIV infection of rhesus macaques results in dysfunctional T- and B-cell responses to neo and recall Leishmania major vaccination
  2. Klatt, N. R.; Vinton, C. L.; Lynch, R. M.; Canary, L. A.; Ho, J.; Darrah, P. A.; Estes, J. D.; Seder, R. A.; Moir, S. L.; Brenchley, J. M.
  3. Blood. 2011, Nov; 118(22): 5803-5812.
  1. 17.   Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques
  2. Kulkarni, V.; Jalah, R.; Ganneru, B.; Bergamaschi, C.; Alicea, C.; von Gegerfelt, A.; Patel, V.; Zhang, G. M.; Chowdhury, B.; Broderick, K. E.; Sardesai, N. Y.; Valentin, A.; Rosati, M.; Felber, B. K.; Pavlakis, G. N.
  3. Vaccine. 2011, Sep; 29(39): 6742-6754.
  1. 18.   Induction of the glucocorticoid-induced leucine zipper gene limits the efficacy of dendritic cell vaccines
  2. Lebson, L.; Wang, T.; Jiang, Q.; Whartenby, K. A.
  3. Cancer Gene Therapy. 2011, Aug; 18(8): 563-570.
  1. 19.   TLR-based immune adjuvants
  2. Steinhagen, F.; Kinjo, T.; Bode, C.; Klinman, D. M.
  3. Vaccine. 2011, Apr; 29(17): 3341-3355.
  1. 20.   Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes
  2. Niu, L. G.; Termini, J. M.; Kanagavelu, S. K.; Gupta, S.; Rolland, M. M.; Kulkarni, V.; Pavlakis, G. N.; Felber, B. K.; Mullins, J. I.; Fischl, M. A.; Stone, G. W.
  3. Vaccine. 2011, Mar; 29(11): 2110-2119.
  1. 21.   Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals
  2. Ho, J.; Moir, S.; Wang, W.; Posada, J. G.; Gu, W. J.; Rehman, M. T.; Dewar, R.; Kovacs, C.; Sneller, M. C.; Chun, T. W.; Follmann, D. A.; Fauci, A. S.
  3. Aids. 2011, Jan; 25(3): 295-302.
  1. 22.   Cloning of guinea pig IL-4: Reduced IL-4 mRNA after vaccination or Mycobacterium tuberculosis infection
  2. Jeevan, A.; Yoshimura, T.; Ly, L. H.; Dirisala, V. R.; McMurray, D. N.
  3. Tuberculosis. 2011, Jan; 91(1): 47-56.
  1. 23.   Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccine
  2. Dauner, J. G.; Pan, Y. J.; Hildesheim, A.; Harro, C.; Pinto, L. A.
  3. Vaccine. 2010, Jul; 28(33): 5407-5413.
  1. 24.   Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit
  2. Valentin, A.; von Gegerfelt, A.; Rosati, M.; Miteloudis, G.; Alicea, C.; Bergamaschi, C.; Jalah, R.; Patel, V.; Khan, A. S.; Draghia-Akli, R.; Pavlakis, G. N.; Felber, B. K.
  3. Vaccine. 2010, Feb; 28(8): 1962-1974.
  1. 25.   Distribution, Persistence, and Efficacy of Adoptively Transferred Central and Effector Memory-Derived Autologous Simian Immunodeficiency Virus-Specific CD8(+) T Cell Clones in Rhesus Macaques during Acute Infection
  2. Minang, J. T.; Trivett, M. T.; Bolton, D. L.; Trubey, C. M.; Estes, J. D.; Li, Y.; Smedley, J.; Pung, R.; Rosati, M.; Jalah, R.; Pavlakis, G. N.; Felber, B. K.; Piatak, M.; Roederer, M.; Lifson, J. D.; Ott, D. E.; Ohlen, C.
  3. Journal of Immunology. 2010, Jan; 184(1): 315-326.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel